...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Canadian journal of hospital pharmacy. >Diversion Inattention: Time for Action!
【24h】

Diversion Inattention: Time for Action!

机译：异民疏远：行动时间！

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Drug diversion, defined as the "unlawful channeling of regulated pharmaceuticals from legal sources to the illicit marketplace", is a problem that is neither new nor rare.1 Opioids are commonly diverted, but benzodiazepines, anabolic steroids, and other noncontrolled agents such as propofol and erythro-poietin are also potential targets. Yet the issue of diversion is not discussed openly in most institutions, and was termed "health care's dirty little secret" in a recent expose on W5, a long-running Canadian documentary television show. In the era of an ongoing and unabating opioid epidemic, in which diversion of opioids from legal sources such as hospitals is one contributing factor (albeit among many others), it is somewhat counterintuitive that pharmacy team members, recognized as guardians of the medication system, are not paying much attention. In fact, a news report from another broadcaster, which was based on data compiled from access to information requests spanning 2010 to 2017, determined that 5689 reports had been filed with Health Canada for various quantities of opioids missing from hospitals.3 What is even more disturbing is that for 4375 (77%) of these reports, the reason for the loss was "unknown".3 These alarming statistics are more than just numbers or scare tactics; they have real clinical, humanistic, and financial consequences.
机译：药物转移，被定义为“非法药物从法律来源到非法市场的非法渠道”，是一种新的，既不是新的也不是稀有的阿片类药物通常是转移的，但苯二氮卓类药物，合成代谢类动物和其他非托管剂如异丙酚和红细胞的潜在目标也是潜在的目标。然而，在大多数机构中，转移问题尚未公开讨论，并在最近的W5曝光中被称为“医疗保健的肮脏小秘密”，这是一款长期的加拿大纪录片电视节目。在持续和不良的阿片类药物流行的时代，其中来自医院等法律来源的异教徒的转移是一个贡献因素（虽然是许多其他人），但药房团队成员有些违反直觉，被认为是药物系统的监护人，不付出很多关注。事实上，来自另一个广播公司的新闻报道，该报告基于从进入2010年至2017年的信息请求编制的数据编制的数据，确定了5689份报告已提交加拿大卫生卫生，以获取医院缺失的各种阿片类药物.3更为困难令人不安的是，对于这些报告的4375（77％），损失的原因是“未知”.3这些惊人的统计数据不仅仅是数字或恐慌策略;他们有真正的临床，人文和财务后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号